We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Mortality analysis among HIV/AIDS cases in Huangshi, Hubei, 2000-2019.
- Authors
XIE Rui-qing; LI Xia; ZHAO Chen-qiao; ZHOU Hong-mei; WANG Qiong; KE Xian-zhou; QIAN Zu-shu
- Abstract
Objective By analyzing the mortality and related factors of HIV / AIDS patients in Huangshi city from 2000 to 2019, we explore the methods of reducing the mortality. Methods Downloading the relevant cards from China's AIDS Prevention and Control Comprehensive System, we analyze the database using excel 2007 and Spass21.0. Results Among the 2 361 HIV /AIDS cases, 760 cases died, the case fatality rate was 32.19%. 600 patients (78.95%) were over 50 years old at the time of death; 73.15% (556/760) patients had received CD4+ T lymphocyte test, of which 65.11% (362/556) patients had detection value<200/µL; 50.79% (386/760) patients had received antiviral therapy; 54.61% (415/760) patients died within one year after diagnosis. Multivariate binomial Logistic regression analysis showed that other patients (OR=5.081, 95%CI=2.776- 9.302), the patients who did not receive antiviral therapy (OR=4.716, 95%CI=3.002-7.407), the CD4+T lymphocyte value <200 /µL (OR=8.550, 95%CI=4.289-17.046) and the patients who did not detect lymphocyte (OR=29.392, 95%CI=13.466-64.155) were more likely to die within one year. The proportion of AIDS related death causes decreased year by year, reaching 39.13% in 2017. The average age of patients at the time of death increased from 37.39 years in 2001 to 66.86 years in 2019. Conclusion The cumulative mortality rate of HIV/AIDS in Huangshi City is higher than the national average, the average age at the time of death was higher than the national average, and the trend is increasing year by year. Late onset cases are more likely to die within one year after diagnosis. The coverage rate of antiretroviral treatment is increasing, and the proportion of non AIDS related deaths and the survival time of patients are increasing. We should continue to carry out early detection and treatment, improve the effect of antiviral therapy, prolong the survival time of patients and reduce the mortality.
- Publication
China Tropical Medicine, 2021, Vol 21, Issue 6, p588
- ISSN
1009-9727
- Publication type
Article
- DOI
10.13604/j.cnki.46-1064/r.2021.06.17